Navigation Links
URI scientists reveal mechanism that regulates cancer-causing gene
Date:3/26/2009

KINGSTON, R.I. March 26, 2009 Two University of Rhode Island scientists have revealed how a cancer causing protein is regulated by reactive oxygen species (ROS) -- a type of stress signal. Their findings provide new insight into how this protein normally behaves in human cells and may help in the design of drugs targeting specific cancers.

Doctoral student David J. Kemble and Professor Gongqin Sun in the URI Department of Cell and Molecular Biology are the first to provide a biochemical mechanism describing how certain protein tyrosine kinases sense and respond to oxidation. This sensing system was found to uniquely apply to two families of proteins implicated in numerous cancers: the Src and Fibroblast Growth Factor Receptor families of tyrosine kinases.

Their results were published online March 9 in the Proceedings of the National Academy of Sciences.

Src was the first enzyme identified as a cancer-causing gene in the early 1900's. For years scientists have been studying how the enzymes are expressed in cancer cells what do they do and what controls them.

According to Kemble and Sun, Src is a master regulator of cell function, controlling cell metabolism, division, and death. In normal cells, the function of Src is turned off, and it is turned on only when certain stimulatory signals activate it. When the regulatory mechanisms that control Src activity are disrupted, Src may be turned on all the time, which turns the host cell into a cancer cell. Thus, it is crucial to understand how Src function is controlled.

Reactive oxygen species have long been viewed as damaging byproducts of oxygen-based metabolism. However, it is now recognized that ROS are produced when the cells are under growth stimulation, and they in turn regulate other cellular events. Accumulating evidence indicates that ROS can directly regulate the function of Src function, and thus indirectly control many cellular processes. Yet how Src responds to this regulation has remained elusive.

The URI scientists took a systematic approach, examined all the potential mechanisms, and identified the sensor that enables Src to respond to ROS regulation. They further found that the sensor is also present in several other similar enzymes, mostly in the FGFR family.

"Our results were surprising at first, given that the results contradict some reports in the literature," Kemble said. "But there was always a very clear answer to each question we asked. It was both unusual and exciting to see things progress as smoothly as it did."

According to Sun, this mechanism of regulation represents just a small piece of the large puzzle of how Src is controlled in the cells. "Src function is under the control of several different mechanisms; each one needs to fit in with the others to form a seamless regulatory system." Sun said.


'/>"/>

Contact: Todd McLeish
tmcleish@uri.edu
401-874-7892
University of Rhode Island
Source:Eurekalert

Related medicine news :

1. Scientists ID New Biomarker for Prostate Cancer
2. Herpes: Scientists find cellular process that fights virus
3. New book chronicles the journeys of women physicians and scientists to fighting cancer
4. University of Washington scientists one step closer to stopping bone loss during spaceflight
5. New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer
6. Biotech company cofounded by BIDMC scientists targets natural killer T-cells
7. Scientists trial device to treat chemotherapy-related nausea
8. Scientists closer to understanding how to control high blood sugar
9. First Treatment for Muscular Dystrophy in Sight: Scientists Harness Exon-Skipping in Large Animal to Successfully Treat Duchenne Muscular Dystrophy
10. First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping
11. Scientists find gene that modifies severity of cystic fibrosis lung disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... 28, 2017 , ... Park Systems , a leader in Atomic Force ... attendees and Park customers on July 11, 2017 from 12-2pm at the Thirsty ... & CEO of Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor in ...
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance and ... to clients in southern Montana, is announcing a focused charity effort to gather ... outreach programs offered by Zoo Montana provide students with current knowledge on the ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... ... protection assistance and financial consultations to communities in northern Virginia and DC, is ... to help provide for patients with Alzheimer’s and other disorders that lead to ...
(Date:6/27/2017)... ... 27, 2017 , ... Excel Medical, the leader in Next-Generation ... of Executive Vice President, Sales and Marketing. Finnegan is a widely known industry ... sales leadership. He has received industry recognition for innovations and new approaches to ...
(Date:6/27/2017)... and London UK (PRWEB) , ... June 27, 2017 , ... ... to a clinical study is whether they can trust the sponsor to pay them ... is vital that sponsors and CROs establish payment strategies that encourage sites to work ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... June 6, 2017  Diplomat Specialty Infusion Group, a brand of ... to its Iowa location. The ... now features an ISO 7 cleanroom—the standard needed to compound ... a low level of pollutants. ... consumers and better serve our Iowa patients," ...
(Date:6/1/2017)... June 1, 2017 Nutriceutical Holdings (NH), parent ... Solutions (VRS), and KD Pharma Group have decided to ... by KD Pharma Group. KD Pharma Group will become ... to acquire the entire company. "We believe ... are committed to growing the NH companies by providing ...
(Date:5/26/2017)...  Endo International plc (NASDAQ: ENDP ) announced ... represent the Company in a fireside chat at Goldman Sachs, ... 13, 2017 at 10:40 a.m. PT / 1:40 p.m. ET. ... Rancho Palos Verdes, CA. A ... available on the Company,s website at http://www.endo.com/investors/overview . Participants ...
Breaking Medicine Technology: